Status:
COMPLETED
Neuropsychological Development and Functional Outcome Sin Children With Hirschsprung Disease at School Age
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Hirschsprung's Disease (HD)
Eligibility:
All Genders
8-13 years
Phase:
NA
Brief Summary
Hirschsprung's disease (HD) is a rare congenital disease (1:5000) characterized by neonatal functional low bowel obstruction that is caused by aganglionosis of the distal bowel. HD treatment consists ...
Eligibility Criteria
Inclusion
- Child aged 8 to 13
- Child with Hirschsprung's disease (diagnosis confirmed by anatomopathological analysis),
- Child with no severe cerebral palsy
- Child with no developmental psychosis
- Child not showing amblyopia
- Child not deaf hearing
- Child able to answer a questionnaire in French language,
- a child whose parents or legal representatives have accepted the principle of participation in this study, and who have signed an informed consent,
Exclusion
- Child deceased between birth and the date of assessment,
- Child with cerebral palsy
- Child whose parents or legal representatives refused to allow their child to participate in this study
Key Trial Info
Start Date :
January 17 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 26 2023
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT03406741
Start Date
January 17 2018
End Date
May 26 2023
Last Update
May 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hôpitaux de Marseille
Marseille, France, 13354